Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas

Marzia Cozzi, Annunziata Gloghini, Sandro Sulfaro, Rachele Volpe, Antonino Carbone

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The total T cell population and T cell subsets in ten lymph nodes with reactive lymphoid hyperplasia (RLH) and 23 specimens (21 lymph nodes, one stomach, and one small bowel) involved by histologically and immunohistologically diagnosed B cell non-Hodgkin's lymphomas (NHLs) were determined by reactivity with monoclonal antibodies Leu 4-CD3, Leu 3-CD4, and Leu 2-CD8 in cytospin preparations from cell suspensions. T cell populations were also investigated for the coexpression of dipeptidylaminopeptidase IV (DAP IV) activity, which was visualized simultaneously with cell surface immunostaining by a combined cytochemical and immunocytochemical method. The mean absolute percentage of Leu 4-CD3+ (total T) and Leu 3-CD4+ cell populations was significantly lower in B cell NHL cases than in RLH cases (35% v 54%, P <.001; 29.5% v 44.4%, P <.01). No difference in the mean absolute percentage of the Leu 2-CD8+ T cell subset was found between the RLH cases and the B cell NHL cases classified as other than category A as described by the Working Formulation (WF) of NHLs. The relative percentage of Leu 4-CD3+ and Leu 2-CD8+ cells coexpressing DAP IV reactivity was lower in B cell NHL cases than in RLH cases (27.3% v 39.5%, P <.05; 13.5% v 24.4%, P <.10). There was no difference in the proportion of Leu 3-CD4+ cells expressing DAP IV reactivity between the NHL and RLH groups (34.5% v 36.1%). Since the mean relative percentage of Leu 2-CD8+ cells expressing DAP IV reactivity in the B cell NHL group in the other than category A according to the WF was lower than that of the RLH group (12.5% v 24.4%), and whereas the mean absolute percentage of total Leu 2-CD8+ cells was similar in the two groups (16.6% and 16.6%), a possible defective role of this Leu 2-CD8+ DAP IV+ subset, at least in B cell NHLs in the other than category A according to the WF, may be hypothesized.

Original languageEnglish
Pages (from-to)987-993
Number of pages7
JournalHuman Pathology
Volume20
Issue number10
DOIs
Publication statusPublished - 1989

Fingerprint

T-Lymphocyte Subsets
B-Cell Lymphoma
Pseudolymphoma
Non-Hodgkin's Lymphoma
Lymph Nodes
Population
T-Lymphocytes
Stomach
Suspensions
Monoclonal Antibodies

Keywords

  • B cell lymphomas
  • cell suspensions
  • dipeptidylaminopeptidase IV
  • T cell subsets

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas. / Cozzi, Marzia; Gloghini, Annunziata; Sulfaro, Sandro; Volpe, Rachele; Carbone, Antonino.

In: Human Pathology, Vol. 20, No. 10, 1989, p. 987-993.

Research output: Contribution to journalArticle

Cozzi, Marzia ; Gloghini, Annunziata ; Sulfaro, Sandro ; Volpe, Rachele ; Carbone, Antonino. / Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas. In: Human Pathology. 1989 ; Vol. 20, No. 10. pp. 987-993.
@article{e314b74012c84e09a1512601eec18d50,
title = "Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas",
abstract = "The total T cell population and T cell subsets in ten lymph nodes with reactive lymphoid hyperplasia (RLH) and 23 specimens (21 lymph nodes, one stomach, and one small bowel) involved by histologically and immunohistologically diagnosed B cell non-Hodgkin's lymphomas (NHLs) were determined by reactivity with monoclonal antibodies Leu 4-CD3, Leu 3-CD4, and Leu 2-CD8 in cytospin preparations from cell suspensions. T cell populations were also investigated for the coexpression of dipeptidylaminopeptidase IV (DAP IV) activity, which was visualized simultaneously with cell surface immunostaining by a combined cytochemical and immunocytochemical method. The mean absolute percentage of Leu 4-CD3+ (total T) and Leu 3-CD4+ cell populations was significantly lower in B cell NHL cases than in RLH cases (35{\%} v 54{\%}, P <.001; 29.5{\%} v 44.4{\%}, P <.01). No difference in the mean absolute percentage of the Leu 2-CD8+ T cell subset was found between the RLH cases and the B cell NHL cases classified as other than category A as described by the Working Formulation (WF) of NHLs. The relative percentage of Leu 4-CD3+ and Leu 2-CD8+ cells coexpressing DAP IV reactivity was lower in B cell NHL cases than in RLH cases (27.3{\%} v 39.5{\%}, P <.05; 13.5{\%} v 24.4{\%}, P <.10). There was no difference in the proportion of Leu 3-CD4+ cells expressing DAP IV reactivity between the NHL and RLH groups (34.5{\%} v 36.1{\%}). Since the mean relative percentage of Leu 2-CD8+ cells expressing DAP IV reactivity in the B cell NHL group in the other than category A according to the WF was lower than that of the RLH group (12.5{\%} v 24.4{\%}), and whereas the mean absolute percentage of total Leu 2-CD8+ cells was similar in the two groups (16.6{\%} and 16.6{\%}), a possible defective role of this Leu 2-CD8+ DAP IV+ subset, at least in B cell NHLs in the other than category A according to the WF, may be hypothesized.",
keywords = "B cell lymphomas, cell suspensions, dipeptidylaminopeptidase IV, T cell subsets",
author = "Marzia Cozzi and Annunziata Gloghini and Sandro Sulfaro and Rachele Volpe and Antonino Carbone",
year = "1989",
doi = "10.1016/0046-8177(89)90270-0",
language = "English",
volume = "20",
pages = "987--993",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas

AU - Cozzi, Marzia

AU - Gloghini, Annunziata

AU - Sulfaro, Sandro

AU - Volpe, Rachele

AU - Carbone, Antonino

PY - 1989

Y1 - 1989

N2 - The total T cell population and T cell subsets in ten lymph nodes with reactive lymphoid hyperplasia (RLH) and 23 specimens (21 lymph nodes, one stomach, and one small bowel) involved by histologically and immunohistologically diagnosed B cell non-Hodgkin's lymphomas (NHLs) were determined by reactivity with monoclonal antibodies Leu 4-CD3, Leu 3-CD4, and Leu 2-CD8 in cytospin preparations from cell suspensions. T cell populations were also investigated for the coexpression of dipeptidylaminopeptidase IV (DAP IV) activity, which was visualized simultaneously with cell surface immunostaining by a combined cytochemical and immunocytochemical method. The mean absolute percentage of Leu 4-CD3+ (total T) and Leu 3-CD4+ cell populations was significantly lower in B cell NHL cases than in RLH cases (35% v 54%, P <.001; 29.5% v 44.4%, P <.01). No difference in the mean absolute percentage of the Leu 2-CD8+ T cell subset was found between the RLH cases and the B cell NHL cases classified as other than category A as described by the Working Formulation (WF) of NHLs. The relative percentage of Leu 4-CD3+ and Leu 2-CD8+ cells coexpressing DAP IV reactivity was lower in B cell NHL cases than in RLH cases (27.3% v 39.5%, P <.05; 13.5% v 24.4%, P <.10). There was no difference in the proportion of Leu 3-CD4+ cells expressing DAP IV reactivity between the NHL and RLH groups (34.5% v 36.1%). Since the mean relative percentage of Leu 2-CD8+ cells expressing DAP IV reactivity in the B cell NHL group in the other than category A according to the WF was lower than that of the RLH group (12.5% v 24.4%), and whereas the mean absolute percentage of total Leu 2-CD8+ cells was similar in the two groups (16.6% and 16.6%), a possible defective role of this Leu 2-CD8+ DAP IV+ subset, at least in B cell NHLs in the other than category A according to the WF, may be hypothesized.

AB - The total T cell population and T cell subsets in ten lymph nodes with reactive lymphoid hyperplasia (RLH) and 23 specimens (21 lymph nodes, one stomach, and one small bowel) involved by histologically and immunohistologically diagnosed B cell non-Hodgkin's lymphomas (NHLs) were determined by reactivity with monoclonal antibodies Leu 4-CD3, Leu 3-CD4, and Leu 2-CD8 in cytospin preparations from cell suspensions. T cell populations were also investigated for the coexpression of dipeptidylaminopeptidase IV (DAP IV) activity, which was visualized simultaneously with cell surface immunostaining by a combined cytochemical and immunocytochemical method. The mean absolute percentage of Leu 4-CD3+ (total T) and Leu 3-CD4+ cell populations was significantly lower in B cell NHL cases than in RLH cases (35% v 54%, P <.001; 29.5% v 44.4%, P <.01). No difference in the mean absolute percentage of the Leu 2-CD8+ T cell subset was found between the RLH cases and the B cell NHL cases classified as other than category A as described by the Working Formulation (WF) of NHLs. The relative percentage of Leu 4-CD3+ and Leu 2-CD8+ cells coexpressing DAP IV reactivity was lower in B cell NHL cases than in RLH cases (27.3% v 39.5%, P <.05; 13.5% v 24.4%, P <.10). There was no difference in the proportion of Leu 3-CD4+ cells expressing DAP IV reactivity between the NHL and RLH groups (34.5% v 36.1%). Since the mean relative percentage of Leu 2-CD8+ cells expressing DAP IV reactivity in the B cell NHL group in the other than category A according to the WF was lower than that of the RLH group (12.5% v 24.4%), and whereas the mean absolute percentage of total Leu 2-CD8+ cells was similar in the two groups (16.6% and 16.6%), a possible defective role of this Leu 2-CD8+ DAP IV+ subset, at least in B cell NHLs in the other than category A according to the WF, may be hypothesized.

KW - B cell lymphomas

KW - cell suspensions

KW - dipeptidylaminopeptidase IV

KW - T cell subsets

UR - http://www.scopus.com/inward/record.url?scp=0024442129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024442129&partnerID=8YFLogxK

U2 - 10.1016/0046-8177(89)90270-0

DO - 10.1016/0046-8177(89)90270-0

M3 - Article

C2 - 2571558

AN - SCOPUS:0024442129

VL - 20

SP - 987

EP - 993

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 10

ER -